Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

AJR 32Sesión 2025

Relating to: designating the first full week in May as Tardive Dyskinesia Awareness Week.

Joint Resolution Text

Skip navigation
  • Home
  • Documents
  • Senate
  • Assembly
  • Committees
  • Service Agencies
  • Docs
  • Options
  • Help
  • 2025 Biennium
  • Statutes
  • Admin. Rules
  • Indices
  • Miscellaneous
  • Archives
  • Home
  • Bill, Rule, and Appointment Histories
  • Senators
  • Representatives
  • Committees
  • Text of Introduced Proposals
  • Amendment Text
  • Acts
  • Veto Messages
  • Enrolled Bills
  • Votes
  • Assembly and Senate Floor Calendars
  • Schedule of Committee Activities
  • Assembly and Senate Journals
  • Committee Records (ROCPs)
  • Legislative Rules
  • All Session-Related Documents
  • Subject Index to Acts
  • Subject Index to Legislation
  • Subject Index to Journals
  • Author Index to Legislation
  • Subject Index to Clearinghouse Rules
  • Miscellaneous Budget Documents
  • Executive Orders
  • Rulings of the Chair
  • Wisconsin Supreme Court Rules
  • Opinions of the Attorney General
  • Town Law Forms
  • Law
  • Districts
  • Session
  • Drafting Files
  • Feeds
  • Preferences
  • Show tree
  • Hide tree
  • Feedback
  • Help
  • Home
  • Senate Home
  • Senators
  • Committees
  • Session
  • Chief Clerk
  • Sergeant at Arms
  • Civics Education
  • Human Resources
  • Assembly Home
  • Representatives
  • Committees
  • Session
  • Chief Clerk
  • Sergeant at Arms
  • Human Resources
  • Schedule
  • Joint
  • Senate
  • Assembly
  • Study
  • Legislative Audit Bureau
  • Legislative Council
  • Legislative Fiscal Bureau
  • Legislative Human Resources Office
  • Legislative Reference Bureau
  • Legislative Technology Services Bureau
  • Menu
  • »2025
  • »Related Documents
  • »Proposal Text
  • »AJR32: Joint Resolution Text
Up Up 2025 - 2026 LEGISLATURELRB-2504/1CMH:emw2025 ASSEMBLY JOINT RESOLUTION 32April 23, 2025 - Introduced by Representatives Moses, Knodl, Melotik, Murphy, O'Connor, Steffen, Clancy, Fitzgerald, Madison, Miresse, Ortiz-Velez, Palmeri, Sinicki, Stubbs, Subeck and J. Jacobson, cosponsored by Senators Cabral-Guevara, Hesselbein, Ratcliff and Spreitzer. Referred to Committee on Rules.AJR32,1,21Relating to: designating the first full week in May as Tardive Dyskinesia
2Awareness Week.AJR32,1,53Whereas, serious mental illnesses like bipolar disorder, major depressive
4disorder, and schizophrenia often require treatment with antipsychotic medications
5for effective management, and antipsychotic prescribing rates continue to rise; andAJR32,1,96Whereas, while prolonged antipsychotic use may be essential for the
7treatment of certain conditions, it is associated with tardive dyskinesia (TD), a
8condition marked by uncontrollable, abnormal, and repetitive movements of the
9face, torso, limbs, or extremities; andAJR32,1,1310Whereas, people at higher risk of TD include those older than 55 years; Black
11individuals; women; individuals with mood or substance use disorders, intellectual
12disabilities, or central nervous system injuries; and those with high cumulative
13antipsychotic exposure; andAJR32,2,314Whereas, approximately 60 percent of the estimated 800,000 U.S. adults
1living with TD remain undiagnosed, and even mild TD symptoms can be
2stigmatizing and impair physical, social, and emotional well-being, underscoring
3the urgency of early screening, detection, and intervention; andAJR32,2,84Whereas, the American Psychiatric Association recommends routine TD
5screening in their clinical guidelines for antipsychotic treatment, and individuals
6treated with antipsychotics or experiencing abnormal movements should consult
7their health care providers to assess TD risk, receive TD screenings, and determine
8appropriate treatment together; andAJR32,2,109Whereas, FDA-approved treatments for TD can provide options for symptom
10management and improved quality of life for many individuals living with TD; andAJR32,2,1411Whereas, the Wisconsin Legislature can encourage TD screening education
12and awareness for health care providers, patients, and care partners to help ensure
13patients prescribed antipsychotics receive care and support that aligns with clinical
14best practice, including regular TD screenings; now, therefore, be it AJR32,2,2015Resolved by the assembly, the senate concurring, That the Wisconsin
16Legislature designates the first full week in May as Tardive Dyskinesia Awareness
17Week, underscores the importance of early detection and intervention to improve
18outcomes for people living with mental health conditions and prescribed
19antipsychotics, and supports efforts to raise awareness about the causes and
20symptoms of TD and the importance of routine TD screening.AJR32,2,2121(end) Down Down /2025/related/proposals/ajr32 true proposaltext /2025/related/proposals/ajr32 proposaltext/2025/REG/AJR32 proposaltext/2025/REG/AJR32 section true
  • Menu
  • »2025
  • »Related Documents
  • »Proposal Text
  • »AJR32: Joint Resolution Text
× Details for
PDF view
Link (Permanent link)
Bookmark this location
View toggle
Go to top of document
Search in this chapter
Search in this section
Search in this agency
Search in this chapter group
Search in this chapter
Search in this section
Cross references for section
Acts affecting this section
References to this
1970 Statutes Annotations
Appellate Court Citations
Administrative Code Index
Reference lines
Clear highlighting

Texto oficial de la Legislatura de Wisconsin. El formato se adaptó para leerlo en Ratifi.